ENANTA PHARMACEUTICALS INC

CIK 1177648 · 839 filings in 37 form types · 2002-06-21 to 2026-11-18 · ENTA

FiledFormCategory8-K items / descriptionAccession
2026-11-18 10-K Financial reports 10-K 0001193125-26-466170
2026-11-16 8-K Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001193125-26-463508
2026-11-16 SCHEDULE 13G Ownership 0001104659-26-128729
2026-11-16 SCHEDULE 13G/A Ownership 0000908834-26-000532
2026-10-29 8-K Current reports 8.01 Other Events 0001193125-26-437774
2026-10-28 8-K Current reports 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits 0001193125-26-435092
2026-10-27 SCHEDULE 13G Ownership 0002052113-26-001073
2026-08-14 SCHEDULE 13G/A Ownership 0001172661-26-003479
2026-08-14 SCHEDULE 13G/A Ownership 0000908834-26-000416
2026-08-12 10-Q Financial reports 10-Q 0001193125-26-345719
2026-08-10 4 Ownership 0002064832-26-000266
2026-08-10 8-K Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001193125-26-342336
2026-07-02 8-K Current reports 1.01 Entry into a Material Definitive Agreement; 9.01 Financial Statements and Exhibits 0001193125-26-294837
2026-07-02 424B5 Registrations and prospectuses 0001193125-26-294828
2026-06-23 8-K Current reports 8.01 Other Events 0001193125-26-279803
2026-06-18 8-K Current reports 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits 0001193125-26-274950
2026-05-13 S-8 Registrations and prospectuses 0001193125-26-220600
2026-05-13 10-Q Financial reports 10-Q 0001193125-26-220572
2026-05-11 8-K Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001193125-26-216735
2026-03-26 8-K Current reports 8.01 Other Events 0001193125-26-125113
2026-03-26 SCHEDULE 13G/A Ownership 0000102909-26-001192
2026-03-13 4 Ownership 0002064832-26-000143
2026-03-13 4 Ownership 0002064832-26-000142
2026-03-13 4 Ownership 0002064832-26-000141
2026-03-13 4 Ownership 0002064832-26-000140
2026-03-13 4 Ownership 0002064832-26-000139
2026-03-13 4 Ownership 0002064832-26-000138
2026-03-12 8-K Current reports 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits 0001193125-26-104109
2026-02-20 EFFECT Registrations and prospectuses 9999999995-26-000642
2026-02-17 CORRESP Other 0001193125-26-055328
2026-02-17 UPLOAD Other 0000000000-26-001607
2026-02-13 4 Ownership 0002064832-26-000016
2026-02-13 4 Ownership 0002064832-26-000014
2026-02-13 4 Ownership 0002064832-26-000012
2026-02-13 4 Ownership 0002064832-26-000010
2026-02-13 4 Ownership 0002064832-26-000008
2026-02-13 4 Ownership 0002064832-26-000006
2026-02-13 SCHEDULE 13G/A Ownership 0001172661-26-000711
2026-02-11 S-3 Registrations and prospectuses 0001193125-26-046712
2026-02-11 10-Q Financial reports 10-Q 0001193125-26-046502
2026-02-09 8-K Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001193125-26-042812
2026-02-05 SCHEDULE 13G/A Ownership 0000908834-26-000042
2026-01-26 ARS Financial reports 0001193125-26-022589
2026-01-26 DEFA14A Proxies 0001193125-26-022585
2026-01-26 DEF 14A Proxies 0001193125-26-022558
2026-01-20 SCHEDULE 13G/A Ownership 0001104659-26-005096
2025-12-05 4 Ownership 0002064832-25-000070
2025-12-05 4 Ownership 0002064832-25-000067
2025-12-05 4 Ownership 0002064832-25-000065
2025-12-05 4 Ownership 0002064832-25-000063